Explore Partnership Opportunities
Everything You Need to Make Your Clinical Trial or Research Project a Success.
Biocept collaborates with leaders in pharmaceutical development, biotechnology, academic research, and more.
Unique technology for rare cell capture and genetic characterization—from a blood test.Learn More
The flexibility you need for modifying rare cell capture and analysis methods for unique requirements.Learn More
A highly skilled, experienced team working in a CLIA-licensed and CAP-accredited laboratory to deliver the most reliable results.Learn More
Capture More CTCs with Biocept’s Unique Technology
Biocept has developed an advanced method for capturing CTCs from a blood sample, using a
novel microfluidic device and antibody capture cocktail for maximum sensitivity. Learn More
Biocept works with you to customize a CTC capture and analysis protocol that meets your unique needs, including:
Biocept, Inc. is a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and biomarker analysis, headquartered in San Diego, California. Our mission is to improve outcomes for cancer patients by advancing oncology diagnostics.Learn More
Get answers to commonly asked questions about Biocept’s liquid biopsy.
Behind Liquid Biopsies
Explore the science that makes it possible for Biocept to Complete the Answer™.
Information for Investors
Discover an opportunity to be a part of a revolutionary medical technology.
Doctors are already using Biocept to establish biomarker status for thousands of patients.